INVEGA Trinza (three month paliperidone palmitate) is now available on the Pharmaceutical Benefits Scheme (PBS) under specific conditions, as the first and only schizophrenia treatment to be administered four times a year as a long-acting atypical antipsychotic.
The above article was sent to subscribers in Pharmacy Daily's issue from 06 Apr 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Apr 17